Rigel Pharmaceuticals, Inc. (RIGL) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 58.82M | 69.8M | 69.46M | 101.69M | 53.33M | 57.6M | 55.31M | 36.84M | 29.53M | 35.79M | 28.13M | 26.89M |
| Revenue Growth % | 10.28% | 21.19% | 25.59% | 176.01% | 80.58% | 60.92% | 96.58% | 37.03% | 13.29% | -30.2% | 25.54% | -9.84% |
| Cost of Goods Sold | 4.61M | 5.96M | 4.75M | 4.5M | 4.41M | 5.79M | 8.03M | 2.81M | 2.02M | 3.79M | 1.27M | 1.07M |
| COGS % of Revenue | 7.83% | 8.53% | 6.84% | 4.43% | 8.27% | 10.05% | 14.51% | 7.62% | 6.86% | 10.59% | 4.51% | 4% |
| Gross Profit | 54.21M | 63.85M | 64.71M | 97.18M | 48.92M | 51.81M | 47.28M | 34.03M | 27.51M | 32M | 26.87M | 25.81M |
| Gross Margin % | 92.17% | 91.47% | 93.16% | 95.57% | 91.73% | 89.95% | 85.49% | 92.38% | 93.14% | 89.41% | 95.49% | 96% |
| Gross Profit Growth % | 10.81% | 23.24% | 36.86% | 185.54% | 77.85% | 61.89% | 75.99% | 31.86% | 9.63% | -37.17% | 21.24% | -10.33% |
| Operating Expenses | 42.33M | 40.68M | 36.29M | 36.08M | 36.15M | 35.15M | 33.23M | 33.59M | 34.48M | 30.04M | 31.33M | 31.08M |
| OpEx % of Revenue | 71.96% | 58.27% | 52.24% | 35.48% | 67.78% | 61.03% | 60.07% | 91.17% | 116.73% | 83.92% | 111.36% | 115.59% |
| Selling, General & Admin | 30.65M | 29.99M | 28.94M | 29.26M | 27.71M | 29.52M | 27.04M | 28.05M | 28.45M | 26.85M | 24.86M | 26.31M |
| SG&A % of Revenue | 52.11% | 42.97% | 41.66% | 28.77% | 51.97% | 51.25% | 48.9% | 76.13% | 96.33% | 75.02% | 88.35% | 97.84% |
| Research & Development | 11.68M | 10.69M | 7.35M | 6.82M | 8.44M | 5.63M | 6.18M | 5.54M | 6.03M | 3.19M | 6.47M | 4.77M |
| R&D % of Revenue | 19.85% | 15.31% | 10.59% | 6.71% | 15.82% | 9.78% | 11.18% | 15.04% | 20.4% | 8.9% | 23.01% | 17.75% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 11.88M | 23.17M | 28.42M | 61.1M | 12.77M | 16.66M | 14.06M | 447K | -6.97M | 1.97M | -4.46M | -5.27M |
| Operating Margin % | 20.21% | 33.19% | 40.91% | 60.09% | 23.95% | 28.92% | 25.41% | 1.21% | -23.59% | 5.49% | -15.87% | -19.59% |
| Operating Income Growth % | -6.95% | 39.12% | 102.19% | 13569.57% | 283.36% | 747.15% | 414.8% | 108.49% | 45.26% | -5.44% | 75.74% | 59.38% |
| EBITDA | 11.88M | 23.77M | 29.02M | 61.71M | 13.38M | 17.26M | 14.67M | 1.06M | -6.57M | 2.26M | -4.17M | -4.97M |
| EBITDA Margin % | 20.21% | 34.05% | 41.78% | 60.69% | 25.08% | 29.97% | 26.52% | 2.88% | -22.23% | 6.31% | -14.83% | -18.49% |
| EBITDA Growth % | -11.15% | 37.73% | 97.88% | 5721.7% | 303.73% | 664.01% | 451.47% | 121.32% | 46.91% | -4.4% | 77.02% | 60.94% |
| D&A (Non-Cash Add-back) | 0 | 601K | 603K | 607K | 604K | 604K | 611K | 613K | 400K | 293K | 292K | 296K |
| EBIT | 11.88M | 20.73M | 29.51M | 61.86M | 13.36M | 17.18M | 14.48M | 999K | -6.37M | 2.64M | -3.79M | -4.74M |
| Net Interest Income | 0 | -456K | -800K | -1.12M | -1.26M | -1.43M | -1.64M | -1.48M | -1.28M | -1.23M | -1.23M | -1.33M |
| Interest Income | 1.21M | 1.24M | 1.09M | 753K | 591K | 522K | 425K | 552K | 593K | 678K | 672K | 529K |
| Interest Expense | -1.43M | 1.7M | 1.89M | 1.87M | 1.85M | 1.96M | 2.06M | 2.03M | 1.87M | 1.91M | 1.9M | 1.86M |
| Other Income/Expense | -228K | -456K | -800K | -1.12M | -1.26M | -1.43M | -1.64M | -1.48M | -1.28M | -1.23M | -1.23M | -1.33M |
| Pretax Income | 11.66M | 22.71M | 27.62M | 59.98M | 11.51M | 15.22M | 12.42M | -1.03M | -8.25M | 737K | -5.69M | -6.6M |
| Pretax Margin % | 19.82% | 32.54% | 39.76% | 58.99% | 21.58% | 26.43% | 22.46% | -2.8% | -27.92% | 2.06% | -20.23% | -24.55% |
| Income Tax | 3M | -245.35M | -280K | 369K | 65K | 881K | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 25.76% | -1080.18% | -1.01% | 0.62% | 0.56% | 5.79% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | 8.65M | 268.06M | 27.9M | 59.61M | 11.45M | 14.34M | 12.42M | -1.03M | -8.25M | 737K | -5.69M | -6.6M |
| Net Margin % | 14.71% | 384.04% | 40.17% | 58.63% | 21.46% | 24.9% | 22.46% | -2.8% | -27.92% | 2.06% | -20.23% | -24.55% |
| Net Income Growth % | -24.39% | 1769.22% | 124.62% | 5887.67% | 238.79% | 1845.86% | 318.22% | 84.39% | 39.07% | -47.39% | 70.1% | 51.08% |
| Net Income (Continuing) | 8.65M | 268.06M | 27.9M | 59.61M | 11.45M | 14.34M | 12.42M | -1.03M | -8.25M | 737K | -5.69M | -6.6M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.44 | 13.54 | 1.46 | 3.28 | 0.63 | 0.80 | 0.70 | -0.06 | -0.47 | 0.04 | -0.33 | -0.38 |
| EPS Growth % | -30.16% | 1592.5% | 108.57% | 5566.67% | 234.04% | 1795.73% | 312.12% | 84.21% | 41.25% | -57.8% | 70% | 52.5% |
| EPS (Basic) | 0.47 | 14.72 | 1.55 | 3.33 | 0.64 | 0.81 | 0.71 | -0.06 | -0.47 | 0.04 | -0.33 | -0.38 |
| Diluted Shares Outstanding | 19.69M | 18.84M | 19.16M | 18.16M | 18.17M | 17.99M | 17.65M | 17.55M | 17.52M | 17.45M | 17.44M | 17.36M |
| Basic Shares Outstanding | 18.41M | 17.99M | 18.04M | 17.89M | 17.81M | 17.65M | 17.6M | 17.55M | 17.52M | 17.45M | 17.44M | 17.36M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |